2/ Here’s stratification by year of patient. As you can see, the post-second dose cases double from age 25 to 21, then double again in the 16-18 range.
The younger you are, the higher the risk.
HOW CAN WE JUSTIFY GIVING THIS TO ANYONE HEALTHY UNDER 25 – MUCH LESS 18? pic.twitter.com/0TGgqVT5aj
— Alex Berenson (@AlexBerenson) June 23, 2021